Financials
- Market Capitalization 62.72 M
- Employee 21
- Founded 2015
- CEO N/A
- Website www.inmunebio.com
- Headquarter Nevada, United States
- FIGI BBG00LW94L98
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-2.59
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4143 | RNTX Rein Therapeutics, Inc. - Common Stock | 0.76 USD | +1.33% | -5.00% | +4.11% | -30.93% | 65.56 M USD | ||
| 4147 | BOLD Boundless Bio, Inc. - Common Stock | 2.86 USD | +1.78% | -4.03% | +14.86% | +146.55% | 65.06 M USD | ||
| 4168 | SER Serina Therapeutics, Inc. Common Stock | 2.46 USD | 0.00% | -7.17% | +22.39% | +47.75% | 62.49 M USD | ||
| 4175 | HRTX Heron Therapeutics, Inc. - Common Stock | 0.32 USD | 0.00% | 0.00% | -36.00% | -76.30% | 60.75 M USD |